Today, the U.S. Food and Drug Administration approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine; the approved vaccine will be marketed as Spikevax for the prevention of COVID-19 in individuals 18 years of age and older.
FDA takes key action by approving second COVID-19 vaccine
January 31, 2022
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022